ELVN
Price
$20.03
Change
+$0.17 (+0.86%)
Updated
Apr 3 closing price
Capitalization
983.52M
34 days until earnings call
RLYB
Price
$0.56
Change
-$0.02 (-3.45%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
23.18M
39 days until earnings call
Ad is loading...

ELVN vs RLYB

Header iconELVN vs RLYB Comparison
Open Charts ELVN vs RLYBBanner chart's image
Enliven Therapeutics
Price$20.03
Change+$0.17 (+0.86%)
Volume$468.76K
Capitalization983.52M
Rallybio
Price$0.56
Change-$0.02 (-3.45%)
Volume$850
Capitalization23.18M
ELVN vs RLYB Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. RLYB commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and RLYB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ELVN: $20.07 vs. RLYB: $0.56)
Brand notoriety: ELVN and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 193% vs. RLYB: 160%
Market capitalization -- ELVN: $983.52M vs. RLYB: $23.18M
ELVN [@Biotechnology] is valued at $983.52M. RLYB’s [@Biotechnology] market capitalization is $23.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, both ELVN and RLYB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 3 TA indicator(s) are bullish while RLYB’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 3 bullish, 5 bearish.
  • RLYB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLYB is a better buy in the short-term than ELVN.

Price Growth

ELVN (@Biotechnology) experienced а -6.69% price change this week, while RLYB (@Biotechnology) price change was -20.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

ELVN is expected to report earnings on May 08, 2025.

RLYB is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($984M) has a higher market cap than RLYB($23.2M). ELVN YTD gains are higher at: -10.978 vs. RLYB (-41.979). RLYB has higher annual earnings (EBITDA): -60.37M vs. ELVN (-104.24M). ELVN has more cash in the bank: 313M vs. RLYB (65.5M). ELVN has less debt than RLYB: ELVN (0) vs RLYB (154K). RLYB has higher revenues than ELVN: RLYB (636K) vs ELVN (0).
ELVNRLYBELVN / RLYB
Capitalization984M23.2M4,241%
EBITDA-104.24M-60.37M173%
Gain YTD-10.978-41.97926%
P/E RatioN/AN/A-
Revenue0636K-
Total Cash313M65.5M478%
Total Debt0154K-
TECHNICAL ANALYSIS
Technical Analysis
ELVNRLYB
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 17 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSLCX9.96N/A
N/A
Putnam Small Cap Value C
AUEIX21.25N/A
N/A
AQR Large Cap Defensive Style I
BGVCX30.59N/A
N/A
Brandes Global Equity C
FTIHX14.28N/A
N/A
Fidelity Total International Index
BISRX20.79N/A
N/A
Brandes International Small Cap EquityR6

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with APGE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.86%
APGE - ELVN
45%
Loosely correlated
-7.51%
DNLI - ELVN
45%
Loosely correlated
-6.91%
CRNX - ELVN
45%
Loosely correlated
-8.03%
ERAS - ELVN
44%
Loosely correlated
-3.97%
CLDX - ELVN
42%
Loosely correlated
-1.32%
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PXXLF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
-3.97%
PXXLF - RLYB
44%
Loosely correlated
N/A
CLYM - RLYB
41%
Loosely correlated
-4.96%
SEOVF - RLYB
34%
Loosely correlated
+7.50%
GBIO - RLYB
34%
Loosely correlated
+7.37%
ELVN - RLYB
33%
Poorly correlated
+1.06%
More